Global Oligonucleotides Market Size, Status and Forecast 2022

Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.

Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.

Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.

North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.

In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.

Market Analysis and Insights: Global Oligonucleotides Market

The global Oligonucleotides market size is projected to reach US$ 2233.7 million by 2027, from US$ 1114 million in 2020, at a CAGR of 10.1% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oligonucleotides market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oligonucleotides market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oligonucleotides market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oligonucleotides market.

Global Oligonucleotides Scope and Market Size

Oligonucleotides market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oligonucleotides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

DNA Oligos

RNA Oligos

Pharmaceutical

Research

Diagnostic

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Integrated DNA Technologies

Agilent

Sigma-aldrich

Eurofins Genomics

L.G.C Biosearch Technologies

Eurogentec S.A

Nitto Denko Avecia Inc

GenScript

BBI Life Sciences

GeneDesign

TriLink BioTechnologies

SGS DNA

LC Sciences

Twist Bioscience

Creative Biogene

General Biosystems

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oligonucleotides Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 DNA Oligos

1.2.3 RNA Oligos

1.3 Market by Application

1.3.1 Global Oligonucleotides Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Pharmaceutical

1.3.3 Research

1.3.4 Diagnostic

1.4 Study Objectives

1.5 Years Considered

2.1 Global Oligonucleotides Market Perspective (2016-2027)

2.2 Oligonucleotides Growth Trends by Regions

2.2.1 Oligonucleotides Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Oligonucleotides Historic Market Share by Regions (2016-2021)

2.2.3 Oligonucleotides Forecasted Market Size by Regions (2022-2027)

2.3 Oligonucleotides Industry Dynamic

2.3.1 Oligonucleotides Market Trends

2.3.2 Oligonucleotides Market Drivers

2.3.3 Oligonucleotides Market Challenges

2.3.4 Oligonucleotides Market Restraints

3.1 Global Top Oligonucleotides Players by Revenue

3.1.1 Global Top Oligonucleotides Players by Revenue (2016-2021)

3.1.2 Global Oligonucleotides Revenue Market Share by Players (2016-2021)

3.2 Global Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Oligonucleotides Revenue

3.4 Global Oligonucleotides Market Concentration Ratio

3.4.1 Global Oligonucleotides Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotides Revenue in 2020

3.5 Oligonucleotides Key Players Head office and Area Served

3.6 Key Players Oligonucleotides Product Solution and Service

3.7 Date of Enter into Oligonucleotides Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Oligonucleotides Historic Market Size by Type (2016-2021)

4.2 Global Oligonucleotides Forecasted Market Size by Type (2022-2027)

5.1 Global Oligonucleotides Historic Market Size by Application (2016-2021)

5.2 Global Oligonucleotides Forecasted Market Size by Application (2022-2027)

6.1 North America Oligonucleotides Market Size (2016-2027)

6.2 North America Oligonucleotides Market Size by Type

6.2.1 North America Oligonucleotides Market Size by Type (2016-2021)

6.2.2 North America Oligonucleotides Market Size by Type (2022-2027)

6.2.3 North America Oligonucleotides Market Size by Type (2016-2027)

6.3 North America Oligonucleotides Market Size by Application

6.3.1 North America Oligonucleotides Market Size by Application (2016-2021)

6.3.2 North America Oligonucleotides Market Size by Application (2022-2027)

6.3.3 North America Oligonucleotides Market Size by Application (2016-2027)

6.4 North America Oligonucleotides Market Size by Country

6.4.1 North America Oligonucleotides Market Size by Country (2016-2021)

6.4.2 North America Oligonucleotides Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7.1 Europe Oligonucleotides Market Size (2016-2027)

7.2 Europe Oligonucleotides Market Size by Type

7.2.1 Europe Oligonucleotides Market Size by Type (2016-2021)

7.2.2 Europe Oligonucleotides Market Size by Type (2022-2027)

7.2.3 Europe Oligonucleotides Market Size by Type (2016-2027)

7.3 Europe Oligonucleotides Market Size by Application

7.3.1 Europe Oligonucleotides Market Size by Application (2016-2021)

7.3.2 Europe Oligonucleotides Market Size by Application (2022-2027)

7.3.3 Europe Oligonucleotides Market Size by Application (2016-2027)

7.4 Europe Oligonucleotides Market Size by Country

7.4.1 Europe Oligonucleotides Market Size by Country (2016-2021)

7.4.2 Europe Oligonucleotides Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8.1 Asia-Pacific Oligonucleotides Market Size (2016-2027)

8.2 Asia-Pacific Oligonucleotides Market Size by Type

8.2.1 Asia-Pacific Oligonucleotides Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Oligonucleotides Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Oligonucleotides Market Size by Type (2016-2027)

8.3 Asia-Pacific Oligonucleotides Market Size by Application

8.3.1 Asia-Pacific Oligonucleotides Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Oligonucleotides Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Oligonucleotides Market Size by Application (2016-2027)

8.4 Asia-Pacific Oligonucleotides Market Size by Region

8.4.1 Asia-Pacific Oligonucleotides Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Oligonucleotides Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Oligonucleotides Market Size (2016-2027)

9.2 Latin America Oligonucleotides Market Size by Type

9.2.1 Latin America Oligonucleotides Market Size by Type (2016-2021)

9.2.2 Latin America Oligonucleotides Market Size by Type (2022-2027)

9.2.3 Latin America Oligonucleotides Market Size by Type (2016-2027)

9.3 Latin America Oligonucleotides Market Size by Application

9.3.1 Latin America Oligonucleotides Market Size by Application (2016-2021)

9.3.2 Latin America Oligonucleotides Market Size by Application (2022-2027)

9.3.3 Latin America Oligonucleotides Market Size by Application (2016-2027)

9.4 Latin America Oligonucleotides Market Size by Country

9.4.1 Latin America Oligonucleotides Market Size by Country (2016-2021)

9.4.2 Latin America Oligonucleotides Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Oligonucleotides Market Size (2016-2027)

10.2 Middle East & Africa Oligonucleotides Market Size by Type

10.2.1 Middle East & Africa Oligonucleotides Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Oligonucleotides Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Oligonucleotides Market Size by Type (2016-2027)

10.3 Middle East & Africa Oligonucleotides Market Size by Application

10.3.1 Middle East & Africa Oligonucleotides Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Oligonucleotides Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Oligonucleotides Market Size by Application (2016-2027)

10.4 Middle East & Africa Oligonucleotides Market Size by Country

10.4.1 Middle East & Africa Oligonucleotides Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Oligonucleotides Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Integrated DNA Technologies

11.1.1 Integrated DNA Technologies Company Details

11.1.2 Integrated DNA Technologies Business Overview

11.1.3 Integrated DNA Technologies Oligonucleotides Introduction

11.1.4 Integrated DNA Technologies Revenue in Oligonucleotides Business (2016-2021)

11.1.5 Integrated DNA Technologies Recent Development

11.2 Agilent

11.2.1 Agilent Company Details

11.2.2 Agilent Business Overview

11.2.3 Agilent Oligonucleotides Introduction

11.2.4 Agilent Revenue in Oligonucleotides Business (2016-2021)

11.2.5 Agilent Recent Development

11.3 Sigma-aldrich

11.3.1 Sigma-aldrich Company Details

11.3.2 Sigma-aldrich Business Overview

11.3.3 Sigma-aldrich Oligonucleotides Introduction

11.3.4 Sigma-aldrich Revenue in Oligonucleotides Business (2016-2021)

11.3.5 Sigma-aldrich Recent Development

11.4 Eurofins Genomics

11.4.1 Eurofins Genomics Company Details

11.4.2 Eurofins Genomics Business Overview

11.4.3 Eurofins Genomics Oligonucleotides Introduction

11.4.4 Eurofins Genomics Revenue in Oligonucleotides Business (2016-2021)

11.4.5 Eurofins Genomics Recent Development

11.5 L.G.C Biosearch Technologies

11.5.1 L.G.C Biosearch Technologies Company Details

11.5.2 L.G.C Biosearch Technologies Business Overview

11.5.3 L.G.C Biosearch Technologies Oligonucleotides Introduction

11.5.4 L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2016-2021)

11.5.5 L.G.C Biosearch Technologies Recent Development

11.6 Eurogentec S.A

11.6.1 Eurogentec S.A Company Details

11.6.2 Eurogentec S.A Business Overview

11.6.3 Eurogentec S.A Oligonucleotides Introduction

11.6.4 Eurogentec S.A Revenue in Oligonucleotides Business (2016-2021)

11.6.5 Eurogentec S.A Recent Development

11.7 Nitto Denko Avecia Inc

11.7.1 Nitto Denko Avecia Inc Company Details

11.7.2 Nitto Denko Avecia Inc Business Overview

11.7.3 Nitto Denko Avecia Inc Oligonucleotides Introduction

11.7.4 Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2016-2021)

11.7.5 Nitto Denko Avecia Inc Recent Development

11.8 GenScript

11.8.1 GenScript Company Details

11.8.2 GenScript Business Overview

11.8.3 GenScript Oligonucleotides Introduction

11.8.4 GenScript Revenue in Oligonucleotides Business (2016-2021)

11.8.5 GenScript Recent Development

11.9 BBI Life Sciences

11.9.1 BBI Life Sciences Company Details

11.9.2 BBI Life Sciences Business Overview

11.9.3 BBI Life Sciences Oligonucleotides Introduction

11.9.4 BBI Life Sciences Revenue in Oligonucleotides Business (2016-2021)

11.9.5 BBI Life Sciences Recent Development

11.10 GeneDesign

11.10.1 GeneDesign Company Details

11.10.2 GeneDesign Business Overview

11.10.3 GeneDesign Oligonucleotides Introduction

11.10.4 GeneDesign Revenue in Oligonucleotides Business (2016-2021)

11.10.5 GeneDesign Recent Development

11.11 TriLink BioTechnologies

11.11.1 TriLink BioTechnologies Company Details

11.11.2 TriLink BioTechnologies Business Overview

11.11.3 TriLink BioTechnologies Oligonucleotides Introduction

11.11.4 TriLink BioTechnologies Revenue in Oligonucleotides Business (2016-2021)

11.11.5 TriLink BioTechnologies Recent Development

11.12 SGS DNA

11.12.1 SGS DNA Company Details

11.12.2 SGS DNA Business Overview

11.12.3 SGS DNA Oligonucleotides Introduction

11.12.4 SGS DNA Revenue in Oligonucleotides Business (2016-2021)

11.12.5 SGS DNA Recent Development

11.13 LC Sciences

11.13.1 LC Sciences Company Details

11.13.2 LC Sciences Business Overview

11.13.3 LC Sciences Oligonucleotides Introduction

11.13.4 LC Sciences Revenue in Oligonucleotides Business (2016-2021)

11.13.5 LC Sciences Recent Development

11.14 Twist Bioscience

11.14.1 Twist Bioscience Company Details

11.14.2 Twist Bioscience Business Overview

11.14.3 Twist Bioscience Oligonucleotides Introduction

11.14.4 Twist Bioscience Revenue in Oligonucleotides Business (2016-2021)

11.14.5 Twist Bioscience Recent Development

11.15 Creative Biogene

11.15.1 Creative Biogene Company Details

11.15.2 Creative Biogene Business Overview

11.15.3 Creative Biogene Oligonucleotides Introduction

11.15.4 Creative Biogene Revenue in Oligonucleotides Business (2016-2021)

11.15.5 Creative Biogene Recent Development

11.16 General Biosystems

11.16.1 General Biosystems Company Details

11.16.2 General Biosystems Business Overview

11.16.3 General Biosystems Oligonucleotides Introduction

11.16.4 General Biosystems Revenue in Oligonucleotides Business (2016-2021)

11.16.5 General Biosystems Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Oligonucleotides Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

    Table 2. Key Players of DNA Oligos

    Table 3. Key Players of RNA Oligos

    Table 4. Global Oligonucleotides Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

    Table 5. Global Oligonucleotides Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

    Table 6. Global Oligonucleotides Market Size by Regions (2016-2021) & (US$ Million)

    Table 7. Global Oligonucleotides Market Share by Regions (2016-2021)

    Table 8. Global Oligonucleotides Forecasted Market Size by Regions (2022-2027) & (US$ Million)

    Table 9. Global Oligonucleotides Market Share by Regions (2022-2027)

    Table 10. Oligonucleotides Market Trends

    Table 11. Oligonucleotides Market Drivers

    Table 12. Oligonucleotides Market Challenges

    Table 13. Oligonucleotides Market Restraints

    Table 14. Global Oligonucleotides Revenue by Players (2016-2021) & (US$ Million)

    Table 15. Global Oligonucleotides Market Share by Players (2016-2021)

    Table 16. Global Top Oligonucleotides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotides as of 2020)

    Table 17. Ranking of Global Top Oligonucleotides Companies by Revenue (US$ Million) in 2020

    Table 18. Global 5 Largest Players Market Share by Oligonucleotides Revenue (CR5 and HHI) & (2016-2021)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Oligonucleotides Product Solution and Service

    Table 21. Date of Enter into Oligonucleotides Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Oligonucleotides Market Size by Type (2016-2021) (US$ Million)

    Table 24. Global Oligonucleotides Revenue Market Share by Type (2016-2021)

    Table 25. Global Oligonucleotides Forecasted Market Size by Type (2022-2027) (US$ Million)

    Table 26. Global Oligonucleotides Revenue Market Share by Type (2022-2027) & (US$ Million)

    Table 27. Global Oligonucleotides Market Size Share by Application (2016-2021) & (US$ Million)

    Table 28. Global Oligonucleotides Revenue Market Share by Application (2016-2021)

    Table 29. Global Oligonucleotides Forecasted Market Size by Application (2022-2027) (US$ Million)

    Table 30. Global Oligonucleotides Revenue Market Share by Application (2022-2027) & (US$ Million)

    Table 31. North America Oligonucleotides Market Size by Type (2016-2021) (US$ Million)

    Table 32. North America Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)

    Table 33. North America Oligonucleotides Market Size by Application (2016-2021) (US$ Million)

    Table 34. North America Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)

    Table 35. North America Oligonucleotides Market Size by Country (2016-2021) & (US$ Million)

    Table 36. North America Oligonucleotides Market Size by Country (2022-2027) & (US$ Million)

    Table 37. Europe Oligonucleotides Market Size by Type (2016-2021) (US$ Million)

    Table 38. Europe Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)

    Table 39. Europe Oligonucleotides Market Size by Application (2016-2021) (US$ Million)

    Table 40. Europe Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)

    Table 41. Europe Oligonucleotides Market Size by Country (2016-2021) & (US$ Million)

    Table 42. Europe Oligonucleotides Market Size by Country (2022-2027) & (US$ Million)

    Table 43. Asia-Pacific Oligonucleotides Market Size by Type (2016-2021) (US$ Million)

    Table 44. Asia-Pacific Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)

    Table 45. Asia-Pacific Oligonucleotides Market Size by Application (2016-2021) (US$ Million)

    Table 46. Asia-Pacific Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)

    Table 47. Asia-Pacific Oligonucleotides Market Size by Region (2016-2021) & (US$ Million)

    Table 48. Asia-Pacific Oligonucleotides Market Size by Region (2022-2027) & (US$ Million)

    Table 49. Latin America Oligonucleotides Market Size by Type (2016-2021) (US$ Million)

    Table 50. Latin America Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)

    Table 51. Latin America Oligonucleotides Market Size by Application (2016-2021) (US$ Million)

    Table 52. Latin America Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)

    Table 53. Latin America Oligonucleotides Market Size by Country (2016-2021) & (US$ Million)

    Table 54. Latin America Oligonucleotides Market Size by Country (2022-2027) & (US$ Million)

    Table 55. Middle East & Africa Oligonucleotides Market Size by Type (2016-2021) (US$ Million)

    Table 56. Middle East & Africa Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)

    Table 57. Middle East & Africa Oligonucleotides Market Size by Application (2016-2021) (US$ Million)

    Table 58. Middle East & Africa Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)

    Table 59. Middle East & Africa Oligonucleotides Market Size by Country (2016-2021) & (US$ Million)

    Table 60. Middle East & Africa Oligonucleotides Market Size by Country (2022-2027) & (US$ Million)

    Table 61. Integrated DNA Technologies Company Details

    Table 62. Integrated DNA Technologies Business Overview

    Table 63. Integrated DNA Technologies Oligonucleotides Product

    Table 64. Integrated DNA Technologies Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 65. Integrated DNA Technologies Recent Development

    Table 66. Agilent Company Details

    Table 67. Agilent Business Overview

    Table 68. Agilent Oligonucleotides Product

    Table 69. Agilent Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 70. Agilent Recent Development

    Table 71. Sigma-aldrich Company Details

    Table 72. Sigma-aldrich Business Overview

    Table 73. Sigma-aldrich Oligonucleotides Product

    Table 74. Sigma-aldrich Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 75. Sigma-aldrich Recent Development

    Table 76. Eurofins Genomics Company Details

    Table 77. Eurofins Genomics Business Overview

    Table 78. Eurofins Genomics Oligonucleotides Product

    Table 79. Eurofins Genomics Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 80. Eurofins Genomics Recent Development

    Table 81. L.G.C Biosearch Technologies Company Details

    Table 82. L.G.C Biosearch Technologies Business Overview

    Table 83. L.G.C Biosearch Technologies Oligonucleotides Product

    Table 84. L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 85. L.G.C Biosearch Technologies Recent Development

    Table 86. Eurogentec S.A Company Details

    Table 87. Eurogentec S.A Business Overview

    Table 88. Eurogentec S.A Oligonucleotides Product

    Table 89. Eurogentec S.A Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 90. Eurogentec S.A Recent Development

    Table 91. Nitto Denko Avecia Inc Company Details

    Table 92. Nitto Denko Avecia Inc Business Overview

    Table 93. Nitto Denko Avecia Inc Oligonucleotides Product

    Table 94. Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 95. Nitto Denko Avecia Inc Recent Development

    Table 96. GenScript Company Details

    Table 97. GenScript Business Overview

    Table 98. GenScript Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 99. GenScript Recent Development

    Table 100. BBI Life Sciences Company Details

    Table 101. BBI Life Sciences Business Overview

    Table 102. BBI Life Sciences Oligonucleotides Product

    Table 103. BBI Life Sciences Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 104. BBI Life Sciences Recent Development

    Table 105. GeneDesign Company Details

    Table 106. GeneDesign Business Overview

    Table 107. GeneDesign Oligonucleotides Product

    Table 108. GeneDesign Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 109. GeneDesign Recent Development

    Table 110. TriLink BioTechnologies Company Details

    Table 111. TriLink BioTechnologies Business Overview

    Table 112. TriLink BioTechnologies Oligonucleotides Product

    Table 113. TriLink BioTechnologies Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 114. TriLink BioTechnologies Recent Development

    Table 115. SGS DNA Company Details

    Table 116. SGS DNA Business Overview

    Table 117. SGS DNA Oligonucleotides Product

    Table 118. SGS DNA Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 119. SGS DNA Recent Development

    Table 120. LC Sciences Company Details

    Table 121. LC Sciences Business Overview

    Table 122. LC Sciences Oligonucleotides Product

    Table 123. LC Sciences Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 124. LC Sciences Recent Development

    Table 125. Twist Bioscience Company Details

    Table 126. Twist Bioscience Business Overview

    Table 127. Twist Bioscience Oligonucleotides Product

    Table 128. Twist Bioscience Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 129. Twist Bioscience Recent Development

    Table 130. Creative Biogene Company Details

    Table 131. Creative Biogene Business Overview

    Table 132. Creative Biogene Oligonucleotides Product

    Table 133. Creative Biogene Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 134. Creative Biogene Recent Development

    Table 135. General Biosystems Company Details

    Table 136. General Biosystems Business Overview

    Table 137. General Biosystems Oligonucleotides Product

    Table 138. General Biosystems Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)

    Table 139. General Biosystems Recent Development

    Table 140. Research Programs/Design for This Report

    Table 141. Key Data Information from Secondary Sources

    Table 142. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Oligonucleotides Market Share by Type: 2020 VS 2027

    Figure 2. DNA Oligos Features

    Figure 3. RNA Oligos Features

    Figure 4. Global Oligonucleotides Market Share by Application: 2020 VS 2027

    Figure 5. Pharmaceutical Case Studies

    Figure 6. Research Case Studies

    Figure 7. Diagnostic Case Studies

    Figure 8. Oligonucleotides Report Years Considered

    Figure 9. Global Oligonucleotides Market Size (US$ Million), Year-over-Year: 2016-2027

    Figure 10. Global Oligonucleotides Market Size (US$ Million), 2016 VS 2021 VS 2027

    Figure 11. Global Oligonucleotides Market Share by Regions: 2020 VS 2027

    Figure 12. Global Oligonucleotides Market Share by Regions (2022-2027)

    Figure 13. Global Oligonucleotides Market Share by Players in 2020

    Figure 14. Global Top Oligonucleotides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotides as of 2020

    Figure 15. The Top 10 and 5 Players Market Share by Oligonucleotides Revenue in 2020

    Figure 16. Global Oligonucleotides Revenue Market Share by Type (2016-2021)

    Figure 17. Global Oligonucleotides Revenue Market Share by Type (2022-2027)

    Figure 18. North America Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 19. North America Oligonucleotides Market Share by Type (2016-2027)

    Figure 20. North America Oligonucleotides Market Share by Application (2016-2027)

    Figure 21. North America Oligonucleotides Market Share by Country (2016-2027)

    Figure 22. United States Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 23. Canada Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 24. Europe Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 25. Europe Oligonucleotides Market Share by Type (2016-2027)

    Figure 26. Europe Oligonucleotides Market Share by Application (2016-2027)

    Figure 27. Europe Oligonucleotides Market Share by Country (2016-2027)

    Figure 28. Germany Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 29. France Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 30. U.K. Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 31. Italy Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 32. Russia Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 33. Nordic Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 34. Asia-Pacific Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 35. Asia-Pacific Oligonucleotides Market Share by Type (2016-2027)

    Figure 36. Asia-Pacific Oligonucleotides Market Share by Application (2016-2027)

    Figure 37. Asia-Pacific Oligonucleotides Market Share by Region (2016-2027)

    Figure 38. China Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 39. Japan Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 40. South Korea Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 41. Southeast Asia Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 42. India Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 43. Australia Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 44. Latin America Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 45. Latin America Oligonucleotides Market Share by Type (2016-2027)

    Figure 46. Latin America Oligonucleotides Market Share by Application (2016-2027)

    Figure 47. Latin America Oligonucleotides Market Share by Country (2016-2027)

    Figure 48. Mexico Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 49. Brazil Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 50. Middle East & Africa Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 51. Middle East & Africa Oligonucleotides Market Share by Type (2016-2027)

    Figure 52. Middle East & Africa Oligonucleotides Market Share by Application (2016-2027)

    Figure 53. Middle East & Africa Oligonucleotides Market Share by Country (2016-2027)

    Figure 54. Turkey Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 55. Saudi Arabia Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 56. UAE Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 57. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 58. Agilent Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 59. Sigma-aldrich Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 60. Eurofins Genomics Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 61. L.G.C Biosearch Technologies Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 62. Eurogentec S.A Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 63. Nitto Denko Avecia Inc Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 64. GenScript Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 65. BBI Life Sciences Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 66. GeneDesign Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 67. TriLink BioTechnologies Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 68. SGS DNA Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 69. LC Sciences Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 70. Twist Bioscience Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 71. Creative Biogene Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 72. General Biosystems Revenue Growth Rate in Oligonucleotides Business (2016-2021)

    Figure 73. Bottom-up and Top-down Approaches for This Report

    Figure 74. Data Triangulation

    Figure 75. Key Executives Interviewed